Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
04/2014
04/09/2014EP2717057A1 Morphine-6-glucuronide derivatives, immunogens and immunoassay
04/09/2014EP2716659A1 Immunoassays for meperidine and metabolites
04/09/2014EP2716658A2 Antibodies and methods for making and using them
04/09/2014EP2716657A2 Antibodies and methods for making and using them
04/09/2014EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
04/09/2014EP2716655A1 Neutralizing antibodies directed against Hepatitis C virus ectodomain glycoprotein E2
04/09/2014EP2714744A1 Lysyl oxidase-like 2 assay and methods of use thereof
04/09/2014EP2714743A1 Magea3 binding antibodies
04/09/2014EP2714742A1 Magea3 binding antibodies
04/09/2014EP2714741A2 Anti-kir antibodies for the treatment of inflammatory disorders
04/09/2014EP2714740A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
04/09/2014EP2714739A1 Humanised anti-cd52 antibodies
04/09/2014EP2714738A2 Multivalent and monovalent multispecific complexes and their uses
04/09/2014EP2714737A1 Bcma (cd269/tnfrsf17) -binding proteins
04/09/2014EP2714736A1 Inhibition of bone resorption with rankl binding peptides
04/09/2014EP2714735A1 Antibodies specific for tgf-beta
04/09/2014EP2714734A1 Method of treating vision disorders
04/09/2014EP2714733A2 Cd3-binding molecules capable of binding to human and non-human cd3
04/09/2014EP2714732A1 METHOD FOR PREPARING Fc-CONTAINING POLYPEPTIDES HAVING IMPROVED PROPERTIES
04/09/2014EP2714731A1 Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders
04/09/2014EP2714730A1 Novel antigen peptide and uses thereof
04/09/2014EP2714729A1 Means and methods for diagnosing and treating multiple sclerosis
04/09/2014EP2714713A1 Purification of antibodies
04/09/2014EP2714198A1 Il-21 epitope and il-21 ligands
04/09/2014EP2714084A1 Fc RECEPTOR BINDING PROTEINS
04/09/2014EP2714078A1 Agents for treating tumours
04/09/2014CN203530191U Multi-channel antibody purifying and collecting device
04/09/2014CN103718045A Method for detecting pancreatic cancer
04/09/2014CN103717740A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717739A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717738A Drug composition for cancer treatment and/or prevention
04/09/2014CN103717737A Cancer treatment and/or prevention drug composition
04/09/2014CN103717620A Use of the antibody I-3859 for the detection and diagnosis of cancer
04/09/2014CN103717619A Anti-kir antibodies for the treatment of inflammatory disorders
04/09/2014CN103717618A Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
04/09/2014CN103717617A Neutralizing anti-influenza a virus antibodies and uses thereof
04/09/2014CN103717284A Purification of biological products by constrained cohydration chromatography
04/09/2014CN103717263A Antibodies that bind to OX40 and their uses
04/09/2014CN103717237A Stabilized formulations containing anti-pcsk9 antibodies
04/09/2014CN103709252A Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
04/09/2014CN103709251A Human anti-CD26 antibody and applications thereof
04/09/2014CN103709250A Human monoclonal antibodies against CD20
04/09/2014CN103709249A Antibodies and methods for making and using them
04/09/2014CN103709248A Anti-TEGV (Transmissible Gastroenteritis Virus) high-immune serum and preparation method thereof
04/09/2014CN103709247A Divalent egg yolk antibodies of type I and novel duck hepatitis as well as preparation method and application thereof
04/09/2014CN103706331A Immunoaffinity column for quickly purifying and enriching cimaterol as well as preparation method and application of immunoaffinity column
04/09/2014CN103705917A M2e synthetic peptide swine influenza virus general vaccine and application
04/09/2014CN103232975B Hybridoma cell strain 2D3, monoclonal antibody to zearalenone secreted by same and application of monoclonal antibody
04/09/2014CN103087154B Polypeptide for preparing monoclonal antibody for detecting acetylcholin esterase and application of polypeptide
04/09/2014CN102643341B 6-methylmercaptopurine (6-MMP) immunogen and 6-(MMP) detection reagent
04/09/2014CN102464706B New rice reference protein and application of rice reference protein monoclonal antibody
04/09/2014CN102286099B Human cytomegalovirus immunoglobulin for intravenous injection and preparation method thereof
04/09/2014CN102103141B Immunity-chromatography kit for rapid diagnosis of malaria and its pathogen species and preparation method thereof
04/09/2014CN102046657B Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
04/09/2014CN101835802B Immunoglobulin constant region Fc receptor binding agents
04/09/2014CN101655494B Fast detection test paper tape of lead ion aurosol immune layer as well as preparation method and application thereof
04/09/2014CN101528259B Human antibodies that bind cxcr4 and uses thereof
04/09/2014CN101511870B Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
04/08/2014US8691956 Monoclonal antibody against human HIG-1 polypeptide
04/08/2014US8691955 Use of α1G subunit of T-type calcium channel as diagnostic marker for pregnancy in cattle
04/08/2014US8691954 Antibody to placental protein having a regulating action on proteolytic activity
04/08/2014US8691953 Binding compounds for IL-27
04/08/2014US8691952 Anti-CD19 antibodies with reduced immunogenicity
04/08/2014US8691951 Type I-type IV collagen hybrid gel
04/08/2014US8691949 Peptide having anti-diabetic activity and use thereof
04/08/2014US8691943 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa
04/08/2014US8691941 Method for producing peptide
04/08/2014US8691938 Anti-viral compounds
04/08/2014US8691773 Peptide compound with biological activity, its preparation and its applications
04/08/2014US8691770 Method for processing microbiologically produced cyclic oligopeptides
04/08/2014US8691233 Antibody molecules having binding specificity for human IL-13
04/08/2014US8691225 Antibodies against the ectodomain of ErbB3 and uses thereof
04/08/2014CA2693137C Engineered scfv against bovine herpes virus type i
04/08/2014CA2580965C Monoclonal antibodies to progastrin
04/08/2014CA2480119C Cripto-specific antibodies
04/08/2014CA2447576C Use of hmg fragment as anti-inflammatory agents
04/03/2014WO2014052672A1 Anti-uroplakin ii antibodies systems and methods
04/03/2014WO2014052620A1 Adcc-mediating antibodies, combinations and uses thereof
04/03/2014WO2014052611A1 Generation of new pancreatic beta cells
04/03/2014WO2014052188A1 Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
04/03/2014WO2014052064A1 Mesothelin antibodies and methods for eliciting potent antitumor activity
04/03/2014WO2014051433A1 BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS
04/03/2014WO2014051412A1 Anti alpha-gal igm monoclonal antibody capable of recognising cells infected with the human papillomavirus, and method for obtaining same
04/03/2014WO2014051109A1 Anti-human bmp9 antibody and treatment agent for ectopic ossification disease containing said antibody as active ingredient
04/03/2014WO2014051022A1 Fgfr3 fusion gene and pharmaceutical drug targeting same
04/03/2014WO2014050779A1 Combination of gsk3 inhibitor and anti-dr5 antibody
04/03/2014WO2014049520A2 Novel epitope and mechanism of antigen-antibody interaction in an influenza virus
04/03/2014WO2014049175A1 Passive immunisation against influenza, in particular h5n1
04/03/2014WO2014049100A1 Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf agents
04/03/2014WO2014049099A1 Pharmaceutical combinations comprising dual angiopoietin-2 / dll4 binders and anti-vegf-r agents
04/03/2014WO2014049087A1 Monoclonal antibodies to growth and differentiation factor 15 (gdf-15)
04/03/2014WO2014049003A1 Purification of hetero-dimeric immunoglobulins
04/03/2014WO2014048921A1 Combinations and uses thereof
04/03/2014WO2014048910A1 Human binding molecules capable of binding to and neutralizing hepatitis b viruses and uses thereof
04/03/2014WO2014047973A1 Monoclonal antibodies specifically recognizing b-raf mutant proteins and preparation method and use thereof
04/03/2014WO2014023952A3 Interleukin-18 inhibitor for use in prevention and treatment of osteoarthritis
04/03/2014WO2014023869A3 Therapeutic use of cd44 inhibitor agents against human acute lymphoblastic leukaemia (all)
04/03/2014WO2014009426A3 Screening of conjugated antibodies
04/03/2014WO2013192596A3 Antigen binding proteins that bind ccr2
04/03/2014WO2013044215A9 Vegf/dll4 binding agents and uses thereof
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 1494